SEK 42.3
(0.83%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 617 Million SEK | -84.84% |
2022 | 4.07 Billion SEK | 11.81% |
2021 | 3.64 Billion SEK | 25.22% |
2020 | 2.9 Billion SEK | 1.71% |
2019 | 2.85 Billion SEK | 10.49% |
2018 | 2.58 Billion SEK | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 1.15 Billion SEK | 705.59% |
2024 Q2 | 255 Million SEK | -77.86% |
2023 Q2 | 1.15 Billion SEK | 7.31% |
2023 FY | 617 Million SEK | -84.84% |
2023 Q4 | 143 Million SEK | -86.83% |
2023 Q3 | 1.08 Billion SEK | -6.3% |
2023 Q1 | 1.08 Billion SEK | -4.09% |
2022 Q1 | 940 Million SEK | -10.13% |
2022 Q4 | 1.12 Billion SEK | 15.61% |
2022 Q3 | 974 Million SEK | -5.53% |
2022 Q2 | 1.03 Billion SEK | 9.68% |
2022 FY | 4.07 Billion SEK | 11.81% |
2021 Q1 | 788 Million SEK | -5.63% |
2021 FY | 3.64 Billion SEK | 25.22% |
2021 Q2 | 915 Million SEK | 16.12% |
2021 Q4 | 1.04 Billion SEK | 17.4% |
2021 Q3 | 891 Million SEK | -2.62% |
2020 FY | 2.9 Billion SEK | 1.71% |
2020 Q3 | 733 Million SEK | 22.37% |
2020 Q1 | 643 Million SEK | 0.0% |
2020 Q4 | 835 Million SEK | 13.92% |
2020 Q2 | 599 Million SEK | -6.84% |
2019 FY | 2.85 Billion SEK | 10.49% |
2018 FY | 2.58 Billion SEK | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
AddLife AB (publ) | 2.77 Billion SEK | 77.75% |
Biotage AB (publ) | 1.14 Billion SEK | 46.301% |
Bonesupport Holding AB (publ) | 533.12 Million SEK | -15.733% |
Doxa AB (publ) | 9.9 Million SEK | -6132.323% |
Elekta AB (publ) | 6.77 Billion SEK | 90.896% |
iZafe Group AB (publ) | 293 Thousand SEK | -210480.205% |
Ortivus AB (publ) | 30.84 Million SEK | -1900.584% |
Ortivus AB (publ) | 30.84 Million SEK | -1900.584% |
Q-linea AB (publ) | 995 Thousand SEK | -61910.05% |
S2Medical AB (publ) | 5.03 Million SEK | -12149.352% |